These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12717089)

  • 21. High dose cyclophosphamide treatment for autoimmune disorders.
    Brodsky RA
    ScientificWorldJournal; 2002 Jun; 2():1808-15. PubMed ID: 12806171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy.
    Al Khalidi H; Kandel G; Streutker CJ
    Hum Pathol; 2006 Mar; 37(3):373-6. PubMed ID: 16613334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged remission induced by cyclosporine in a patient with familial thrombocytopenia and enteropathy.
    Beck MN; Kuchler H; Roulet M; Beck D
    Pediatr Hematol Oncol; 1995; 12(3):289-93. PubMed ID: 7640183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible autoimmune enteropathy found in autistic children.
    Senior K
    Lancet; 2002 May; 359(9318):1674. PubMed ID: 12020535
    [No Abstract]   [Full Text] [Related]  

  • 25. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune enteropathy with onset in early infancy: clinico-morphologic and immunologic manifestations].
    Sýkora J; Varvarovská J; Stozický F; Kobr J; Pizingerová K; Schejbalová E; Tláskalová H; Tucková L; Sedivá A; Janatková I; Gutová V
    Cas Lek Cesk; 2002 Oct; 141(20):646-50. PubMed ID: 12515041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.
    Dhaygude A; Griffith M; Cairns T; McLean A; Palmer A; Taube D
    Nephron Clin Pract; 2004; 97(4):c154-9. PubMed ID: 15331939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulse-dose cyclophosphamide therapy for steroid-refractory autoimmune neurological diseases].
    Watanabe T; Shimoji S; Sugiyama Y; Tsukamoto T; Yamamoto T
    Rinsho Shinkeigaku; 1995 Jun; 35(6):611-6. PubMed ID: 8521635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune enteropathy: a review and update of clinical management.
    Gentile NM; Murray JA; Pardi DS
    Curr Gastroenterol Rep; 2012 Oct; 14(5):380-5. PubMed ID: 22810979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal goblet cell autoantibody associated enteropathy.
    Hori K; Fukuda Y; Tomita T; Kosaka T; Tamura K; Nishigami T; Kubota A; Shimoyama T
    J Clin Pathol; 2003 Aug; 56(8):629-30. PubMed ID: 12890820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoimmune enteropathy--difficulties in diagnosis and treatment].
    Popińska K; Lyszkowska M; Ksiazyk J; Kierkuś J; Socha J
    Pediatr Pol; 1996 Jan; 71(1):57-60. PubMed ID: 8966068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
    Nousari HC; Brodsky RA; Jones RJ; Grever MR; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):750-4. PubMed ID: 10321604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type B Insulin Resistance in Peru.
    Zelada H; Gamarra D; Arbañil H; Manrique H
    Am J Med Sci; 2017 Mar; 353(3):258-262. PubMed ID: 28262212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune enteropathy in a pediatric patient: partial response to tacrolimus therapy.
    Steffen R; Wyllie R; Kay M; Kyllonen K; Gramlich T; Petras R
    Clin Pediatr (Phila); 1997 May; 36(5):295-9. PubMed ID: 9152557
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoimmune enteropathy.
    Russo PA; Brochu P; Seidman EG; Roy CC
    Pediatr Dev Pathol; 1999; 2(1):65-71. PubMed ID: 9841709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pediatric autoimmune enteropathies with anti-cytoplasmic enterocytic auto-antibodies].
    Charritat JL; Polonovski C
    Ann Pediatr (Paris); 1987 Mar; 34(3):195-203. PubMed ID: 3296919
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases.
    Dan D; Fischer R; Adler S; Förger F; Villiger PM
    Swiss Med Wkly; 2014; 144():w14030. PubMed ID: 25341028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
    Fernandes das Neves M; Caetano J; Oliveira S; Delgado Alves J
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26240092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide pulse therapy for rapidly progressive interstitial pneumonia in dermatomyositis. A new possibility for rescue?
    Takizawa H; Ito K
    Intern Med; 1997 Jul; 36(7):448-9. PubMed ID: 9240490
    [No Abstract]   [Full Text] [Related]  

  • 40. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.